Clinical Trial Update: Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 trial compares tenofovir alone versus tenofovir plus entecavir in patients with entecavir-resistant chronic hepatitis B and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D

Drugs mentioned

• Baraclude (entecavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Asan Medical Center | Conditions: Chronic Viral Hepatitis B Without Delta-agent | Phase 4 | Status: COMPLETED